NL7007707A - - Google Patents

Info

Publication number
NL7007707A
NL7007707A NL7007707A NL7007707A NL7007707A NL 7007707 A NL7007707 A NL 7007707A NL 7007707 A NL7007707 A NL 7007707A NL 7007707 A NL7007707 A NL 7007707A NL 7007707 A NL7007707 A NL 7007707A
Authority
NL
Netherlands
Application number
NL7007707A
Other versions
NL170419B (nl
NL170419C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7007707A publication Critical patent/NL7007707A/xx
Publication of NL170419B publication Critical patent/NL170419B/xx
Application granted granted Critical
Publication of NL170419C publication Critical patent/NL170419C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NLAANVRAGE7007707,A 1969-05-29 1970-05-28 Werkwijze voor het afscheiden van specifieke, niet van virus afkomstige proteinen uit bloedplasma of serum. NL170419C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82914769A 1969-05-29 1969-05-29

Publications (3)

Publication Number Publication Date
NL7007707A true NL7007707A (cg-RX-API-DMAC7.html) 1970-12-01
NL170419B NL170419B (nl) 1982-06-01
NL170419C NL170419C (nl) 1982-11-01

Family

ID=25253656

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7007707,A NL170419C (nl) 1969-05-29 1970-05-28 Werkwijze voor het afscheiden van specifieke, niet van virus afkomstige proteinen uit bloedplasma of serum.

Country Status (7)

Country Link
US (1) US3555001A (cg-RX-API-DMAC7.html)
BE (1) BE751088A (cg-RX-API-DMAC7.html)
CA (1) CA925017A (cg-RX-API-DMAC7.html)
DE (1) DE2026076C3 (cg-RX-API-DMAC7.html)
FR (1) FR2048934A5 (cg-RX-API-DMAC7.html)
GB (1) GB1269868A (cg-RX-API-DMAC7.html)
NL (1) NL170419C (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1412274A (en) * 1973-05-29 1975-11-05 Bio Rad Laboratories Radioactive determination of serum thyroxine
NL7708005A (nl) * 1976-07-22 1978-01-24 Monsanto Co Werkwijze voor de bereiding van serumalbumine.
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
US4055469A (en) * 1976-12-10 1977-10-25 Eastman Kodak Company Purification of microbial enzyme extracts using synthetic polyelectrolytes
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
ES471858A1 (es) * 1977-07-25 1979-02-01 Monsanto Co Un metodo para separar el factor especifico de coagulacion de la sangre de una mezcla con otras proteinas de la sangre en un medio fluido
US4118554A (en) * 1977-07-25 1978-10-03 Monsanto Company Aggregated polyelectrolytes
JPS5843369B2 (ja) * 1977-09-10 1983-09-27 森六株式会社 血清蛋白質の分画方法
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US4471112A (en) * 1982-06-28 1984-09-11 Monsanto Company Heparin polyelectrolyte polymer complex
US4382028A (en) * 1982-07-19 1983-05-03 Monsanto Company Separation of plasma proteins from cell culture systems
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures
US4981914A (en) * 1987-08-12 1991-01-01 Atochem North America, Inc. Polymer bound UV stabilizers
US4857595A (en) * 1987-08-12 1989-08-15 Pennwalt Corporation Polymer bound hindered amine light stabilizers
US4975489A (en) * 1987-08-12 1990-12-04 Atochem North America, Inc. Process for preparing polymer bound hindered amine light stabilizers
US5206378A (en) * 1987-08-12 1993-04-27 Elf Atochem North America, Inc. Hydrazido functionalized 2-(2-hydroxyphenyl)-2h-benzotriazoles
US4981915A (en) * 1987-08-12 1991-01-01 Atochem North America, Inc. Multipurpose polymer bound stabilizers
US5096974A (en) * 1987-08-12 1992-03-17 Atochem North America, Inc. Process for preparing multipurpose polymer bound stabilizers and polymer bound stabilizer produced thereby
US4868246A (en) * 1987-08-12 1989-09-19 Pennwalt Corporation Polymer bound UV stabilizers
US4866136A (en) * 1987-08-12 1989-09-12 Pennwalt Corporation Process for producing polymer bound hindered amine light stabilizers
US4857596A (en) * 1987-08-12 1989-08-15 Pennwalt Corporation Polymer bound antioxidant stabilizers
US5096977A (en) * 1987-08-12 1992-03-17 Atochem North America, Inc. Process for preparing polymer bound UV stabilizers
US4863999A (en) * 1987-08-12 1989-09-05 Pennwalt Corporation Multipurpose polymer bound stabilizers
US4981917A (en) * 1987-08-12 1991-01-01 Atochem North America, Inc. Process for preparing polymer bound antioxidant stabilizers
US5220015A (en) * 1988-11-07 1993-06-15 Elf Atochem North America, Inc. Flame retardants compounds
US5037894A (en) * 1988-11-07 1991-08-06 Atochem North America, Inc. Polymer bound flame retardants
US5140070A (en) * 1988-11-07 1992-08-18 Elf Atochem North America, Inc Compositions comprising polymer bond flame retardants
US4958782A (en) * 1988-12-28 1990-09-25 Pitney Bowes Inc. Reeled tape supply
JPH0778025B2 (ja) * 1990-03-20 1995-08-23 日本赤十字社 免疫グロブリンｇの製造方法
US5320812A (en) * 1993-10-04 1994-06-14 Becton, Dickinson And Company Clot activating polyelectrolyte complex and blood collection assembly containing same
US9764319B2 (en) * 2011-06-02 2017-09-19 Universidad De Santiago De Chile Biomarkers related with a supra-nutritional metabolic state of selenium and diagnosis method in which said biomarkers are identified
WO2013039449A1 (en) 2011-09-16 2013-03-21 Ge Healthcare Bio-Sciences Ab Plasma protein fractionation by sequential polyacid precipitation
WO2025118020A1 (en) * 2023-12-07 2025-06-12 The University Of Queensland A polymer for improved purification of extracellular vesicles

Also Published As

Publication number Publication date
FR2048934A5 (cg-RX-API-DMAC7.html) 1971-03-19
DE2026076C3 (de) 1980-01-03
DE2026076B2 (de) 1979-05-10
DE2026076A1 (cg-RX-API-DMAC7.html) 1970-12-03
NL170419B (nl) 1982-06-01
BE751088A (fr) 1970-11-30
NL170419C (nl) 1982-11-01
CA925017A (en) 1973-04-24
US3555001A (en) 1971-01-12
GB1269868A (en) 1972-04-06

Similar Documents

Publication Publication Date Title
FR2048934A5 (cg-RX-API-DMAC7.html)
AU465452B2 (cg-RX-API-DMAC7.html)
AU429630B2 (cg-RX-API-DMAC7.html)
AU450150B2 (cg-RX-API-DMAC7.html)
CS150732B1 (cg-RX-API-DMAC7.html)
AU442375B2 (cg-RX-API-DMAC7.html)
AU2355770A (cg-RX-API-DMAC7.html)
AU470301B1 (cg-RX-API-DMAC7.html)
CS151573B2 (cg-RX-API-DMAC7.html)
AU5113869A (cg-RX-API-DMAC7.html)
AU442357B2 (cg-RX-API-DMAC7.html)
AU470661B1 (cg-RX-API-DMAC7.html)
AU442322B2 (cg-RX-API-DMAC7.html)
AU442380B2 (cg-RX-API-DMAC7.html)
AU442463B2 (cg-RX-API-DMAC7.html)
AU442535B2 (cg-RX-API-DMAC7.html)
AU442538B2 (cg-RX-API-DMAC7.html)
AU442554B2 (cg-RX-API-DMAC7.html)
AU442285B2 (cg-RX-API-DMAC7.html)
AU438128B2 (cg-RX-API-DMAC7.html)
AU428131B2 (cg-RX-API-DMAC7.html)
AU428129B2 (cg-RX-API-DMAC7.html)
AU5228269A (cg-RX-API-DMAC7.html)
CS153191B1 (cg-RX-API-DMAC7.html)
AU4540468A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent